시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 엑소좀 연구 시장 보고서(2025년)
Exosome Research Global Market Report 2025
상품코드 : 1824276
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 엑소좀 연구 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년까지 연평균 복합 성장률(CAGR) 31.7%로 확대되어 1조 1,461억 9,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 엑소좀 기반 치료의 임상 응용, 액체생검 응용의 확대, 연구에서 산업 연계 증가, 세포외 소포에 대한 관심 증가, 표준화와 품질 관리의 중시에 기인하는 것으로 예측됩니다. 예측기간의 주요 동향으로는 임상 응용과 치료, 분리 및 분석에서의 기술진보, 바이오마커의 발견과 진단, 표준화와 품질관리, 공동연구와 파트너십 등이 있습니다.

향후 5년간의 성장률 31.7%라는 예측은 지난 예측으로부터 0.2% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 한국과 스위스에서 개발된 엑소좀 분리 키트 및 분석 도구의 가격을 상승시켜 바이오마커 탐색 지연과 R&D 비용 상승을 초래하여 미국의 생물의학적 진보를 방해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

엑소좀 연구 시장의 성장이 예상되는 배경에는 만성 질환 증가가 있습니다. 만성 질환은 3개월 이상 지속되며, 종종 시간이 지남에 따라 악화되는 것으로, 암, 심장병, 뇌졸중, 당뇨병, 관절염 등의 일반적인 질병이 포함됩니다. 엑소좀의 방출은 면역체계의 검출을 회피하기 위해 감염증에 의해 악용될 가능성이 있으며, 암, 신경퇴행성 질환, 염증성 질환을 포함한 다양한 질환의 이해와 대처에 있어서의 엑소좀 연구의 중요성을 부각하고 있습니다. 예를 들어 2022년 7월 미국 질병 예방관리센터가 발표한 보고서에 따르면 미국인 10명 중 6명이 만성 질환을 앓고 있으며 성인 10명 중 4명이 만성 폐질환, 심장병, 뇌졸중, 당뇨병 등 2개 이상의 만성질환을 경험하고 있음이 밝혀졌습니다. 그 결과 만성 질환의 이환율이 증가하면 엑소좀 연구시장의 성장을 가속하게 됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Exosomes, the smallest extracellular vesicles (EVs), hold significant relevance in the tumor microenvironment (TME), where they play a direct role in facilitating angiogenesis, tumor metastasis, and immunosuppression. EVs, which encompass exosomes, can be categorized into three primary groups based on their size, biogenesis, and function.

The primary components of exosome research comprise kits and reagents, as well as instruments and other related tools. Kits and reagents are specialized test kits designed for use in laboratory settings or field environments to detect specific compounds. These kits find applications in various indications such as cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, among others. Additionally, they serve different purposes such as biomarker identification, vaccine development, tissue regeneration, and more. End-users of these products include academic and research institutes, pharmaceutical and biotechnology companies, as well as hospitals and clinical testing laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The exosome research market research report is one of a series of new reports from The Business Research Company that provides exosome research market statistics, including exosome research industry global market size, regional shares, competitors with an exosome research market share, detailed exosome research market segments, market trends and opportunities, and any further data you may need to thrive in the exosome research industry. This exosome research market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome research market size has grown exponentially in recent years. It will grow from $284.9 billion in 2024 to $381.11 billion in 2025 at a compound annual growth rate (CAGR) of 33.8%. The growth in the historic period can be attributed to a growing understanding of exosome biology, increasing investment in life sciences research, the emergence of liquid biopsies, increased focus on personalized medicine, and collaborative research initiatives.

The exosome research market size is expected to see exponential growth in the next few years. It will grow to $1146.19 billion in 2029 at a compound annual growth rate (CAGR) of 31.7%. The growth in the forecast period can be attributed to clinical translation of exosome-based therapeutics, expansion of liquid biopsy applications, increased industry collaboration in research, rising interest in extracellular vesicles, and focus on standardization and quality control. Major trends in the forecast period include clinical applications and therapeutics, technological advancements in isolation and analysis, biomarker discovery and diagnostics, standardization and quality control, collaborations and partnerships.

The forecast of 31.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biomedical advancements by inflating prices of exosome isolation kits and analytical tools developed in South Korea and Switzerland, resulting in slower biomarker discovery and higher research lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the exosome research market is attributed to the increased incidence of chronic medical diseases. Chronic diseases, lasting three months or longer and often worsening over time, include common ailments such as cancer, heart disease, stroke, diabetes, and arthritis. The release of exosomes can be exploited by infections to avoid immune system detection, highlighting the significance of exosome research in understanding and addressing various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. For instance, a report from the Centers for Disease Control and Prevention in July 2022 revealed that 6 out of 10 Americans suffer from chronic diseases, with 4 out of 10 adults experiencing more than two chronic conditions, such as chronic lung disease, heart disease, stroke, and diabetes. Consequently, the increased incidence of chronic medical diseases is set to drive the growth of the exosome research market.

The expected rise in funding for life sciences research is another factor contributing to the growth of the exosome research market. Funding for life sciences research involves financial support provided to scientists, researchers, and organizations for conducting studies in the life sciences field. This increased funding has generated a growing interest in exosome research, particularly in the realms of disease diagnosis and therapeutic applications. The availability of funds has facilitated innovative approaches to exosome research, leveraging advanced technologies and methodologies to explore exosome biology and function. For instance, statistics from the National Center for Science and Engineering in September 2023 indicated a 13.6% increase in federal agency commitments for research and experimental development (R&D) in FY 2021, reaching an all-time high of $190.2 billion (in current dollars) from $167.4 billion in FY 2020. Thus, the rising funding for life sciences research is a driving force behind the growth of the exosome research market.

Product innovations emerge as a prominent trend gaining traction in the exosome research market, with major companies actively introducing inventive products to foster market growth. A case in point is the November 2022 launch by Cell Guidance Systems, a UK-based company, of Instant Exosomes and the LipoQ assay. Instant Exosomes, a subtype of extracellular vesicles (EV), are lipid membrane-enclosed compartments within the 50 to 1,000 nm diameter range. These EVs, released from various cell types and tissues, exhibit highly diverse contents. The LipoQ assay, based on the sulfo-phospo-vanillin method, facilitates the measurement of lipid content, particularly unsaturated fatty acids, within a given sample.

Major players in the exosome research market are strategically focusing on technological innovations, including the development of exosome characterization platforms, to gain a competitive advantage. These platforms encompass a set of tools and techniques dedicated to analyzing the physical, molecular, and functional properties of exosomes. Creative Biolabs Inc., a US-based biotech products and services provider, exemplifies this strategy by launching the Nanosight platform in August 2022. The Nanosight platform, designed specifically for exosome characterization, enhances accessibility and efficiency in exosome research for global researchers. It proves invaluable for researchers exploring the potential applications of exosomes in diverse fields such as medicine, diagnostics, and drug delivery.

In August 2024, BioIVT LLC, a U.S.-based provider of biospecimen solutions, acquired ZenBio Inc. for an undisclosed amount. This acquisition enables BioIVT to strengthen its expertise in cell and tissue models, broadening its range of high-quality biological products for research and drug development. ZenBio Inc., also based in the U.S., is a biotechnology company specializing in human exosome research products.

Major companies operating in the exosome research market include Thermo Fisher Scientific Inc., System Biosciences LLC, QIAGEN N.V., Exosome Diagnostics Inc., Bio-Techne Corporation, Hitachi Ltd., Aethlon Medical Inc., NanoSomiX Inc., Malvern Panalytical Ltd., Sistemic Scotland Limited, NX PharmaGen Corporation, Miltenyi Biotec GmbH, AMS Biotechnology (Europe) B.V., Norgen Biotek Corp., Novus Biologicals LLC, Lonza Group AG, Sistem-Bio S.A.S., Izon Science Ltd, Evomic Science LLC, New England Biolabs Inc., Evox Therapeutics Limited, Codiak BioSciences Inc., MagBio Genomics Inc., Cell Guidance Systems Ltd., Aruna Biomedical PBC, Capricor Therapeutics Inc., Stemcell Technologies Inc., ExoCoBio Inc., Creative Biolabs, Nanovex Biotechnologies S.L.

North America was the largest region in the exosome research market in 2024. The regions covered in the exosome research market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome research market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The exosome research market consists of sales of exosome research tools, exosome isolation and detection tools, exosome marker antibodies, and exosome biomarkers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Research Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome research market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for exosome research ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exosome research market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Exosome Research Market Characteristics

3. Exosome Research Market Trends And Strategies

4. Exosome Research Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Exosome Research Growth Analysis And Strategic Analysis Framework

6. Exosome Research Market Segmentation

7. Exosome Research Market Regional And Country Analysis

8. Asia-Pacific Exosome Research Market

9. China Exosome Research Market

10. India Exosome Research Market

11. Japan Exosome Research Market

12. Australia Exosome Research Market

13. Indonesia Exosome Research Market

14. South Korea Exosome Research Market

15. Western Europe Exosome Research Market

16. UK Exosome Research Market

17. Germany Exosome Research Market

18. France Exosome Research Market

19. Italy Exosome Research Market

20. Spain Exosome Research Market

21. Eastern Europe Exosome Research Market

22. Russia Exosome Research Market

23. North America Exosome Research Market

24. USA Exosome Research Market

25. Canada Exosome Research Market

26. South America Exosome Research Market

27. Brazil Exosome Research Market

28. Middle East Exosome Research Market

29. Africa Exosome Research Market

30. Exosome Research Market Competitive Landscape And Company Profiles

31. Exosome Research Market Other Major And Innovative Companies

32. Global Exosome Research Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exosome Research Market

34. Recent Developments In The Exosome Research Market

35. Exosome Research Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기